Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-08

Clinical Trial Update: Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma

View source ↗

Summary

A prospective study evaluating first-line Helicobacter pylori eradication for early-stage extragastric mucosa-associated lymphoid tissue lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Mucosa-Associated Lymphoid Tissue Lymphoma | Status: UNKNOWN